Clinical Trials Directory

Trials / Completed

CompletedNCT04581135

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Prospective Observational Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
620 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19.

Detailed description

COVID-19 is a coronavirus induced viral pneumonia leading to Acute Respiratory Distress Syndrome. Previous coronavirus infections (SARS and MERS) led to pulmonary fibrosis in up to 30%. Prospective evaluation of lung abnormalities and pulmonary fibrosis after COVID-19 infection is crucial as novel treatments against lung fibrosis of different etiologies are available. No data on pulmonary longterm effects in COVID-19 survivors are currently available. The nation-wide Swiss COVID-19 lung group establishes a meticulously characterized prospective cohort study on pulmonary long-term sequela of patients living in Switzerland.

Conditions

Interventions

TypeNameDescription
OTHERCOVID-19Research project in which biological material is sampled and health-related personal data are collected and used for further research. Coded data are used.

Timeline

Start date
2020-05-01
Primary completion
2022-01-30
Completion
2022-01-30
First posted
2020-10-09
Last updated
2023-03-14

Locations

9 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04581135. Inclusion in this directory is not an endorsement.